CARDIAC ABLATION CATHETERS | GLOBAL MARKETS

104 Pages | 29 Exhibits | 2017 Analysis | Forecasts Through 2021 Product Family: Market Reports




OVERVIEW:
This analysis includes a discussion of products, competitors, market forecasts, and opportunities in the global market for cardiac ablation catheters.

CARDIAC ABLATION CATHETERS MARKET HIGHLIGHTS

  • The global market for cardiac ablation catheters is seeing strong single-digit compound annual growth due to a number of factors, including: new guidelines encouraging cardiac ablation usage, positive clinical trial data supporting cardiac ablation, and improved catheter ablation technologies.
  • In 2016, the majority of total cardiac ablation catheter sales were attributable to sales of RF catheters, which made up approximately 85% of total sales
  • The market for cardiac ablation catheters is anticipated to experience strong CAGR of 9.7% during the forecast period (2016-21), reaching approximately $2.6bn in total product sales by 2021.
  • Major suppliers of cardiac ablation catheters in 2016 included Biosense Webster, Boston Scientific, Medtronic, and St. Jude Medical. These four comanies accounted for approximately 93% of global cardiac ablation catheter sales in 2016.
  • The US market for cardiac ablation catheters accounted for approximately 33.4% of total sales in 2016, and will remain the largest market throughout this report's forecast period.
Topics Covered Include:
  • An overview of cardiac ablation catheter products, radiofrequency (RF)-based ablation catheters, cryoablative, and laser-based catheters.
  • Global and country/region-specific market forecasts, including forecasts by product segment.
  • Competitive analyses by product segment.
  • Discussion of key drivers and limiters impacting the major product segments.
  • Country and region-specific insights that are influencing the utilization of cardiac ablation catheters and the performance of cardiac catheter ablation procedures.
  • A review of emerging technologies which could impact sales of existing devices.


TABLE OF CONTENTS:
EXECUTIVE SUMMARY 

i. Methodology 

Exhibit ES-1: Global cardiac catheter ablation procedures, share by country/region, 2016 
Exhibit ES-2: Global cardiac ablation catheter products market, share by country/region, 2016 and 2021 
Exhibit ES-3: Global cardiac ablation catheter products market, by product, 2016 and 2021 

1. CARDIAC RHYTHM DISORDERS OVERVIEW
 
1.1 Sick sinus syndrome 
1.2 Heart block 
1.3 Tachycardia 
1.4 Atrial fibrillation 
1.5 Ventricular fibrillation 
1.6 Heart failure 
1.7 Bibliography 

Exhibit 1-1: Estimated prevalence rates of conduction disorders and cardiac arrhythmias across the US, Japan, and five major EU markets 
Exhibit 1-2: Estimated prevalence of atrial fibrillation across the US, Japan, and five major EU markets, 2015 

2. CARDIAC ABLATION CATHETER PRODUCTS
 
2.1 Catheter ablation procedures 
2.2 Technology 
	2.2.1 Radio frequency ablation 
	2.2.2 Cryoablation 
	2.2.3 Laser ablation 
	2.2.4 Types of catheters 
		2.2.4.1 Multi-electrode catheters 
		2.1.4.2 Balloon catheters 
		2.1.4.3 Contact force systems 
	2.2.5 Imaging and mapping 
		2.2.5.1 Electroanatomic mapping/multi-modality mapping/image integration systems 
		2.2.5.2 Ultrasound mapping 
		2.2.5.3 MRI-guided mapping 
2.3 Clinical trials 
	2.3.1 Persistent AF 
	2.3.2 Paroxysmal AF 
	2.3.3 Heart failure 
	2.3.4 Ventricular tachycardia 
2.4 Guidelines 
2.5 Cardiac catheter ablation products 
	2.5.1 Biosense Webster/Johnson & Johnson 
	2.5.2 Boston Scientific 
	2.5.3 Medtronic 
	2.5.4 St. Jude Medical/Abbott
	2.5.5 Cardiofocus 
	2.5.6 Japan Lifeline 
	2.5.7 MicroPort Scientific 
	2.5.8 Toray Industries 
	2.5.9 Other companies 
	2.5.10 Products in development 
2.6 Bibliography 

Exhibit 2-1: Alternative targeting techniques to pulmonary vein isolation for other AF triggers 
Exhibit 2-2: Ongoing randomized trials of catheter ablation of atrial fibrillation in patients with heart failure 
Exhibit 2-3: Key Heart Rhythm Society joint guideline recommendations 
Exhibit 2-4: 2017 Recommendations for AF catheter ablation
 
3. CARDIAC ABLATION CATHETERS MARKET
 
3.1 Procedures forecast: global 
	3.1.1 Procedures by type of arrhythmia forecast: global 
		3.1.1.1 Atrial fibrillation 
		3.1.1.2 Supraventricular tachycardias 
		3.1.1.3 Ventricular arrhythmias 
	3.1.2 Procedures by type of arrhythmia forecast: US 
	3.1.3 Procedures forecast: five major EU markets 
	3.1.4 Procedures forecast: Japan 
	3.1.5 Procedure forecast: Rest of World 
3.2 Market forecast: global 
	3.2.1 Global competitors 
	3.2.2 Market forecast: US 
		3.2.2.1 US competitors 
	3.2.3 Market forecast: five major EU markets 
		3.2.3.1 European competitors 
	3.2.4 Market forecast: Japan 
		3.2.4.1 Japanese competitors 
	3.2.5 Market forecast: Rest of the World 
		3.2.5.1 Rest of the World competitors 
3.3 Bibliography 

Exhibit 3-1: Global cardiac catheter ablation procedures, combined forecast, 2016-21 
Exhibit 3-2: Global cardiac ablation procedures by country/region, 2016-21 
Exhibit 3-3: Global cardiac catheter ablation procedures, share by country/region, 2016 
Exhibit 3-4: Global cardiac catheter ablation procedures, forecast by type of arrhythmia, 2016-21 
Exhibit 3-5: US cardiac catheter ablation procedures, forecast by type, 2016-21 
Exhibit 3-6: Five major EU markets cardiac catheter ablation procedures, procedure volumes forecast, 2016-21 
Exhibit 3-7: Japanese cardiac catheter ablation procedures, procedure volumes forecast, 2016-21 
Exhibit 3-8: Rest of World cardiac catheter ablation procedures, procedure volumes forecast, 2016-21 
Exhibit 3-9: Global cardiac catheter ablation, combined market forecast ($m), 2016-21 
Exhibit 3-10: Global cardiac ablation catheter sales by country/region, combined market forecast ($m), 2016-21 
Exhibit 3-11: Global cardiac ablation catheter market ($m), share by country/region, 2016 
Exhibit 3-12: Global cardiac ablation catheter market, share by supplier, 2016 
Exhibit 3-13: US cardiac ablation catheter sales, market forecast ($m), 2016-21 
Exhibit 3-14: US cardiac ablation catheters, share by supplier, 2016 
Exhibit 3-15: Five major EU markets cardiac ablation catheter sales, market forecast ($m), 2016-2021 
Exhibit 3-16: Five major EU markets cardiac ablation catheters market, share by supplier, 2016 
Exhibit 3-17: Japanese cardiac ablation catheter sales, market forecast ($m), 2016-2021 
Exhibit 3-18: Japanese cardiac ablation catheters market, share by supplier, 2016 
Exhibit 3-19: Rest of the world cardiac ablation catheter sales, market forecast ($m), 2016-21 
Exhibit 3-20: Rest of World cardiac ablation catheters market, share by supplier, 2016 

APPENDIX: COMPANY LISTING 


COMPANIES COVERED:

  1. Advanced Cardiac Therapeutics (ACT)
  2. Afreeze GmbH
  3. Apama Medical
  4. Boston Scientific Corporation
  5. Biosense Webster/Johnson & Johnson
  6. Biotronik
  7. CathRx Ltd
  8. Imricor Medical Systems
  9. MedLumics SL
  10. Medtronic
  11. Osypka
  12. St. Jude Medical, Inc./Abbott
  13. Toray Industries
Contact Us

Need help finding medtech research? Let us help you!